跳至主要内容
临床试验/NCT04932785
NCT04932785招募中不适用

To Assess the Comparative Efficacy of Full Calorie Regular Diet (RD) Versus Clear Liquid Diet (CLD) on Length of Hospital Stay (LOHS) for Mild to Moderate Acute Pancreatitis (AP)

University of Southern California2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2021年7月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
2
主要终点
Length of Hospitalization Stay

研究概览

简要总结

Acute pancreatitis is among the most common gastroenterology diagnosis in the United States, and represents a large economic burden to the United States health system. While recent guidelines agree early feeding shortens length of stay, these guidelines fail to provide recommendations on optimal diet to start leaving diet type to clinician discretion. Therefore, the aim is to assess the comparative efficacy of full calorie regular diet (RD) versus clear liquid diet (CLD) on length of hospital stay (LOHS) for mild to moderate acute pancreatitis (AP). The study population will target mild to moderate acute pancreatitis patients who can tolerate eating in a single institution. The primary end point will focus on LOHS, and secondary end points will include Pancreatic Activity Scoring System, side effects and readmission.

详细描述

Purpose: To assess the comparative efficacy of initial full calorie regular diet (RD) versus clear liquid diet (CLD) on length of hospital stay (LOHS) for mild to moderate acute pancreatitis (AP).

Study Design:

Patients presenting to the Los Angeles County Hospital with mild to moderate acute pancreatitis are eligible and are the focus population of this study. Diagnosis and severity classification will be according to the Revised Atlanta classification and Modified Marshal Score. Patients will require fulfillment of 2 of 3 criteria: amylase or lipase greater than 3 times the upper limit of normal, classic epigastric abdominal pain, or unequivocal imaging consistent with acute pancreatitis.

Patients within the inclusion and exclusion parameters will be randomized to RD vs. CLD within 16 hours of diagnosis of pancreatitis. Randomization will be performed using a random sequence algorithm with concealed allocation. The provision of diet in the emergency department prior to randomization will be recorded but not impact randomization strategy.

Following randomization, the diet of RD vs. CLD will begin as soon as patient expresses an appetite and willingness to eat. The patients will be assessed within 24 hours for hunger and interest in initiating oral feeding which accords with the 2018 recommendations of the American Gastroenterology Association for the management of acute pancreatitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >18 years of age
  • Presentation with acute pancreatitis as defined by two of three criterion per the Revised Atlanta Criteria guidelines: (a) Amylase or lipase > 3x the upper limit of normal, b) Classical abdominal pain, c) Ultrasound or computed tomography of unequivocal pancreatitis. Such radiographic findings include swelling, edema, or heterogeneity of the gland or peripancreatic fluid or stranding

排除标准

  • Pregnant or breastfeeding women
  • Incarcerated patients
  • Patients < 18 years of age
  • Patient unable or unwilling to give informed consent
  • Patients transferred from another hospital
  • The possibility of poor oral intake for reasons other than acute pancreatitis (e.g. intubation, failure to pass an indicated swallow study for aspiration risk, anorexia secondary to active malignancy, etc)
  • Surgical intervention for infected pancreatic necrosis or pancreatic hemorrhage
  • Chronic pancreatitis based on radiographic evidence
  • Severe pancreatitis based on Revised Atlanta Criteria. Under Revised Atlanta Criteria, patients will be excluded if they have a composite Modified Marshall >2
  • Etiologies of hypertriglyceridemia, trauma and autoimmune pancreatitis will be excluded

结局指标

主要结局

Length of Hospitalization Stay

时间窗: From date of randomization until the date of discharge, assessed up to 24 months

Length of Hospitalization Stay will be measured as defined as from time of admission to time of discharge for regular diet vs. clear liquid diet

次要结局

  • Oral Intolerance(From date of randomization until the date of discharge, assessed up to 24 months)
  • Local complications(From date of randomization until the date of discharge, assessed up to 24 months)
  • Change in Pancreatic Activity Scoring System Score(From date of randomization until the date of discharge at 24, 48, 72 hours and at discharge, assessed up to 24 months)
  • 30 day hospital readmission(From date of discharge to 30 days after discharge)
  • Intensive Care Unit admission and interventions(From date of randomization until the date of discharge, assessed up to 24 months)
  • Calorie and fat intake(From date of randomization until the date of discharge, assessed up to 24 months)
  • Development of severe pancreatitis(From date of randomization until the date of discharge, assessed up to 24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

James Buxbaum

Chief of Gastroenterology Los Angeles County + University of Southern California

University of Southern California

研究点 (2)

Loading locations...

相似试验